Walk into enough Australian gyms, or scroll enough fitness content, and peptides come up constantly — growth-hormone secretagogues, IGF-1 analogues, recovery peptides, all framed as the next step beyond supplements. The marketing is slick and the promises are big.
What rarely gets mentioned is the stack of risks underneath. For someone considering peptides for muscle or performance, the legal, quality and anti-doping problems don’t apply one at a time — they apply together. This article lays them out plainly.
What’s actually being marketed
The peptides pitched for muscle and performance are mostly growth-hormone-related: secretagogues such as CJC-1295, ipamorelin and hexarelin, alongside IGF-1 analogues like IGF-1 LR3, and recovery peptides used to train through damage. The pitch is more growth hormone, faster recovery, leaner physique.
Almost all of these are sold as “research” products — the same “not for human use” framing seen across the unapproved peptide market. That label is the first clue that you’re outside the regulated system.
Most are unapproved
With limited exceptions, the performance peptides marketed to bodybuilders are not ARTG-approved and have no lawful consumer supply pathway. They’re sold through the grey and black markets, not pharmacies.
That means there’s no approved product, no quality oversight, and no lawful supply to fall back on. The convenience of ordering online masks the fact that the entire transaction sits outside the system designed to keep medicines safe.
Three risks stacked together
For someone weighing these up, three separate problems apply simultaneously:
A specific note on growth hormone
Recombinant human growth hormone (somatropin) deserves its own mention, because it’s genuinely a registered medicine — but only for defined medical indications, such as diagnosed growth-hormone deficiency. General muscle-building is not one of them.
Using it outside those indications is both higher-risk and tightly restricted, and it requires monitoring even in legitimate clinical use (for effects like fluid retention, joint symptoms and glucose changes). It’s also prohibited in sport. “It’s a real medicine” is true, but it doesn’t make non-medical bodybuilding use lawful or safe.
The health risks people downplay
Beyond legality and testing, there are direct health considerations. These products manipulate hormonal systems, often in combinations, in healthy people, without medical assessment or monitoring. The long-term effects of much of this use simply aren’t well characterised, and the unregulated supply adds contamination and dosing risk on top.
The marketing frames peptides as a low-risk edge. In reality, the combination of unknown product quality, unmonitored hormonal effects and no professional oversight is a meaningful gamble with your health — not a refined biohack.
Frequently asked questions
Most performance peptides aren’t ARTG-approved and have no lawful consumer supply pathway. Recombinant growth hormone is a prescription medicine restricted to specific medical indications.
“Safer” is the wrong frame for an unregulated product of unknown quality used without oversight. For both, the dominant risk is the unregulated supply and lack of monitoring.
Many are prohibited in sport under the WADA Code, often at all times, and detection methods continue to improve. For tested athletes the risk is serious.